Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - aciclovir -

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - aciclovir 200mg; aciclovir 200mg - dispersible tablet - 200 mg - active: aciclovir 200mg excipient: aluminium magnesium silicate hypromellose indigo carmine macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate active: aciclovir 200mg excipient: aluminium magnesium silicate hypromellose macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide - zovirax dispersible tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. zovirax dispersible tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. zovirax dispersible tablets are indicated for the prophylaxis of herpes simplex infections in immune-compromised patients.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - aciclovir 400mg; aciclovir 400mg - dispersible tablet - 400 mg - active: aciclovir 400mg excipient: aluminium magnesium silicate hypromellose iron oxide red macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate active: aciclovir 400mg excipient: aluminium magnesium silicate hypromellose macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide - zovirax dispersible tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. zovirax dispersible tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. zovirax dispersible tablets are indicated for the prophylaxis of herpes simplex infections in immune-compromised patients.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - aciclovir 800mg - dispersible tablet - 800 mg - active: aciclovir 800mg excipient: aluminium magnesium silicate hypromellose macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide - zovirax dispersible tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. zovirax dispersible tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. zovirax dispersible tablets are indicated for the prophylaxis of herpes simplex infections in immune-compromised patients.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - aciclovir -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - aciclovir -

Izrael - angličtina - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - cream - aciclovir 5 %w/w - aciclovir - aciclovir - zovirax genital is indicated for local treatment of genital herpes simplex virus infections.

Singapur - angličtina - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - acyclovir - ointment - 3% w/w - acyclovir 3% w/w

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - aciclovir -

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - aciclovir 250mg (as the freeze -dried sodium salt) - powder for infusion - 250 mg - active: aciclovir 250mg (as the freeze -dried sodium salt) excipient: sodium hydroxide water for injection - zovirax iv for infusion is indicated for the treatment of herpes simplex infections. zovirax iv for infusion is indicated for the prophylaxis of herpes simplex infections in immune compromised patients. zovirax iv for infusion is indicated in the treatment of varicella zoster infections. zovirax iv for infusion is indicated for the treatment of herpes simplex infections in the neonate. zovirax iv for infusion is indicated for prophylaxis of cmv infection in bone marrow transplant recipients. it has been shown that high dose intravenous zovirax reduces the incidence and delays the onset of cmv infection. when high dose intravenous zovirax is followed by 6 months treatment with high dose oral zovirax (see prescribing information for oral zovirax) mortality and the incidence of viraemia are also reduced.